Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Steve Cohen, SAC Capital Reveal 5.3% Stake in Intercept Pharmaceuticals

Steve Cohen‘s SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates. The filing, which is a 13G, indicates that Cohen is here for investment purposes only, and does not seek any activist changes.

Steven Cohen

Disclosure: none

Recommended Reading:

Karpus Management Ups Stakes in Zweig Total Return Fund and Western Asset Inflation Management Fund

This Week’s 6 Most Important Hedge Fund Moves

Alan Fournier, Pennant Capital Boost Stake in BioScrip

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!